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Objectives: To analyse the results of gamma knife radiosurgery (GKS) for the trreatment of intracranial
meningiomas and to assess possible factors related to the outcome and complications of such
treatment.
Methods: The authors retrospectively reviewed the clinical and radiological data of 179 patients (194
lesions) treated with GKS for meningiomas between May 1992 and October 2000. The mean follow
up duration was 37.3 months (range 6.4 to 86.3 months). The study determined the correlation
between radiosurgical outcome including imaging changes after GKS and multiple factors such as
tumour location and size, patient characteristics, venous sinus status, pre-GKS degree of oedema, other
treatment modalities, and radiosurgical parameters.
Results: The radiological control rate was 97.1%. Magnetic resonance imaging (MRI) showed compli-
cations after GKS in 35 lesions (25.0%) among the 140 lesions followed up with MRI. Complications
were divided into peritumorous imaging changes (33 lesions; 23.6%) and transient cranial nerve dys-
function (two lesions; 1.4%). Radiation induced imaging changes were seen mostly in convexity, para-
sagittal, and falx meningiomas that were deeply embedded in the cortex. About 60% of these were
asymptomatic and the overall rate of symptomatic imaging changes was 9.3%. Neurological deficit
related to imaging changes developed in only three patients, and all the symptoms were transient.
Conclusion: GKS for intracranial meningiomas seems to be a safe and effective treatment. However,
meningiomas of the convexity, parasagittal region, or falx cerebri have a higher incidence of peritu-
morous imaging changes after GKS than those of the skull base. Therefore, the use of GKS needs to be
considered very cautiously in cerebral hemispheric meningiomas, taking into consideration patient age
and general condition, tumour size and location, pattern of cortical embedding, relation between the
tumour and venous sinuses, presenting symptoms, and patient preference.
Although more than 90% of intracranial meningiomas arehistopathologically benign, they frequently recur ifremoval is incomplete.1–9 While surgical approaches and
techniques for these tumours have undergone continual
development, their complete removal remains difficult,
especially for parasellar, cavernous, orbital, and petroclival
meningiomas and meningiomas adjacent to the major venous
sinuses. As a result, the role of radiosurgery has been increas-
ing in importance as a primary or adjuvant treatment
modality.1–6 8–16 Meningiomas are suitable for radiosurgery,
because they are encapsulated and often small at time of
diagnosis, usually do not invade the brain, and are well
defined by computed tomography or magnetic resonance
imaging (MRI). These features allow steep radiation fall off
and precise definition of target volume. Because their blood
supply usually arises from the dura, it can be included in the
treatment volume, and this can cause tumour infarction and
necrosis.5
Recent advances in high resolution imaging technique and
sophisticated three dimensional workstations have improved
the accuracy of dose planning during gamma knife radiosur-
gery (GKS).6 Nevertheless, there have been major and minor
complications after GKS, so proper selection of meningiomas
for GKS is still very important. We, therefore, analysed the
radiosurgical outcomes and complications resulting from
treatment of benign meningiomas with GKS and further
evaluated potential aetiologies of treatment complications.
METHODS
Between May 1992 and October 2000, 187 patients with men-
ingiomas were treated with GKS at our institution. This group
represented 28.5% of all brain tumours treated with GKS.
After we excluded one atypical meningioma and seven malig-
nant meningiomas from this study, we retrospectively
reviewed the clinical and radiological data in 194 lesions of
179 patients treated with GKS for intracranial meningiomas.
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Figure 1 The degree of peritumorous oedema: the diameter of
oedema (A+B in cm) from the tumour margin (T) on T2WI MRI.
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There were nine patients withmultiple meningiomas.We used
the KULA dose planning system (version 5.4, Elekta, Sweden;
164 lesions) until September 1999, when we began using the
GammaPlan (version 5.30, Elekta, Sweden; 30 lesions).
Among the 194 lesions, 140 lesions (72.2%) were radiologi-
cally followed up for more than six months with MRI and the
mean follow up duration was 37.3 months (range 6.4 to 86.3
months). When the volume of a tumour decreased by more
than 20% of pre-GKS volume on follow upMRI, it was defined
as shrinkage and represented as the volume response of a
tumour to GKS. When it changed by less than 20%, or
increased by more than 20%, it was defined as stasis or
enlargement, respectively. Shrinkage and stasis were defined
as radiological controls. The degree of peritumorous oedema
was graded by first subtracting the maximal diameter (cm) of
the tumour from that of the peritumorous oedema on the T2
weighted MR image and then rounding off the result to the
nearest whole number (fig 1). The grade 0 indicates that there
was no peritumorous oedema and increasing grade indicates
increasing severity of the peritumorous oedema.
A Cox proportional hazards model was used to evaluate the
correlation between radiosurgical outcomes and imaging
changes after GKS and various factors such as tumour
location, lobar location and size, patient age, sex, and present-
ing symptom, relation to major venous sinus, pre-GKS degree
of oedema, treatment modality, and various radiosurgical
parameters (maximum tumour dose, tumour margin dose,
and type of software used for dose planning). Significance was
assigned as p less than 0.05.
RESULTS
Patient characteristics
The mean age of the patients at the time of radiosurgery was
50.4 years (range 7.4 to 82.2 years). The ratio of male to female
patients was 1:3.5 (40 male and 139 female patients). The
most common presenting symptoms were headache in 55
patients (30.7%), trigeminal neuralgia in 18 (10.1%), and
visual disturbance in 13 (7.3%). In 49 patients (27.4%), the
meningiomas were incidentally detected.
Radiological findings
Most of the tumours were located in the skull base (n=112;
57.7%), and cerebral hemispheres (n=72; 37.1%). The rest
were in the ventricles, pineal region, or sylvian fissure (n=10;
5.2%). Cerebral hemispheric meningiomas included convexity,
parasagittal, and falx meningiomas. Among the 72 hemi-
spheric meningiomas, 42 (58.3%) were located in the frontal
region, 18 (25.0%) in the parietal region, four (5.6%) in the
occipital region, three (4.2%) in the temporal region, and five
(6.9%) in the cerebellar convexity.
The relation between tumour and major venous sinus was
classified into three groups: complete occlusion of venous
sinus due to tumour invasion (n=2, 1.0%); partial occlusion of
venous sinus (n=21, 10.8%); and no venous sinus invasion
(n=171, 88.1%).
Pre-GKS peritumorous oedema, grade 1 to 6, was found in
26 lesions (13.4%).
Treatment modalities
Of the 179 patients, GKS was performed as a primary
treatment in 109 (60.9%) and as an adjuvant treatment for
residual or recurrent lesions after surgical resection in the
other 70 (39.1%). No patient received conventional radiation
therapy.
Radiosurgical parameters
The volume of tumour was estimated by the area within the
isodose curve during dose planning. The mean volume of
tumours was 10.1 cc (range 0.6 to 45 cc). The tumour was
covered within 40% to 90% (mean 50.5%) of the isodose curve;
the mean tumour margin dose was 15.1 Gy (range 9.5 to 24.5
Gy); the mean maximum tumour dose was 30.0 Gy (range 19
to 45 Gy); and the mean number of isocentres was 6.3 (range
1 to 15).
Radiological response
Of the 140 lesions (72.2%) followed up for more than six
months with MRI, shrinkage was found in 77 (55.0%), stasis
in 59 (42.1%), and enlargement in four (2.9%). Radiological
control, either shrinkage or stasis was achieved in 136 of 140
lesions, giving a radiological control rate of 97.1%. The
probability of radiological control after GKS was analysed
with Kaplan-Meier analysis (fig 2). We have provided
additional data on the four intracranial meningiomas that
failed GKS (table 1). We were unable to identify statistically
significant factors related to radiological control of meningi-
omas or failure of treatment after GKS.
Table 1 Summary of failed cases after GKS (n=4)
No Sex/age (y) Location Max/margin (Gy) Volume (cc) Recur time (m) Result Remarks
1 M/37 Convexity 31/15.5 21 81 C/R
2 M/39 Petroclival 25/12.5 5 63 Re-GKS
3 M/65 Convexity 32/16 5.5 28 Observation Multiple
4 F/63 Parasagittal 30/13.5 26 11 F/U loss
GKS, gamma knife radiosurgery; C/R, craniotomy and removal of tumour.
Figure 2 Cumulative events curve by Kaplan-Meier analysis for
radiological control of meningiomas after GKS.






Cerebral hemispheric 26/52 (50.0) 11/52 (21.2)
Convexity 12/22 (54.5) 4/22 (18.2)
Parasagittal 11/15 (73.3) 6/15 (40)
Falx 3/15 (20.0) 1/15 (6.7)
Skull base 4/79 (5.1) 1/79 (1.3)
Other 3/9 (33.3) 1/9 (11.1)
Total 33/140 (23.6)* 13/140 (9.3)*
*MRI follow up (>6 months) in 140/194 lesions (72.2%). GKS,
gamma knife radiosurgery; IC, imaging changes.
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Complications
Complications after GKS for meningiomas were found in 35
lesions (25.0%) among the 140 lesions followed up with MRI.
Complications were divided into peritumorous imaging
changes on follow up MRI in 33 lesions (23.6%) and transient
cranial nerve dysfunction in the other two (1.4%). Peritu-
mourous imaging changes included newly developed imaging
changes and aggravation of pre-existing imaging changes on
follow up MRI after GKS (fig 3). Among the 33 peritumorous
lesions, 13 (39.4%) produced either headaches, caused by
increased intracranial pressure (six lesions); seizures (four
lesions); or other neurological deficits (three lesions). The
symptoms were all transient. The overall rate of symptomatic
oedema was 9.3%. Imaging changes developed at a mean of
7.8 months (range 2.8 to 48.9 months) after GKS and were
sustained for 13.5 months (range 3.0 to 28.0 months). Imag-
ing changes were evident in four (5.1%) of the 79 skull base
meningiomas and 26 (50.0%) of the 52 hemispheric meningi-
omas. The symptomatic imaging changes occurred more
frequently in hemispheric meningiomas (table 2).
The cranial nerve dysfunction seen in two patients was also
transient. The first patient had undergone GKS for a
cavernous meningioma extending to the orbital fossa. The
tumour margin dose was 16.5 Gy and the estimated dose to
the lateral wall of the cavernous sinus was 16.5 Gy. Decreased
hemifacial sensation developed six months after GKS and was
present for one month. The second patient with a cavernous
meningioma had undergone GKS with 13.3 Gy of tumour
margin dose. The estimated dose to the cavernous sinus was
18.6 Gy. The patient developed an abducens nerve palsy at 18
months after GKS but improved two months later.
We analysed the factors related to peritumorous imaging
changes on MRI after GKS. In univariate analysis, tumour
location (p<0.001), maximum tumour dose (p=0.0002), and
tumour margin dose (p=0.037) were significantly related to
imaging changes after GKS.However, in multivariate analysis,
only tumour location was significant. Cerebral hemispheric
meningiomas had a higher rate of peritumorous imaging
changes after GKS than tumours at other locations such as the
skull base, ventricles, pineal region, or sylvian fissure.
Figure 3 (A) Pre-radiosurgical MRI
showing an incidental convexity
meningioma. (B-F) Follow up
computed tomography (4, 5, 8, 12,
and 16 months after GKS,
respectively) showing recurrent
peritumorous imaging changes. The
imaging changes responded well to
corticosteroid treatment. Sixteen
months after GKS the imaging
changes were completely improved
and the tumour was slightly shrunken.
Figure 4 Difference of growth
pattern between skull base
meningiomas and cerebral
hemispheric meningiomas. While the
first usually expand laterally along
cisterns, the second such as
convexity, parasagittal, and falx
meningiomas grow deeply
embedding into the cortex.
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DISCUSSION
The role of radiosurgery has been gaining importance as a pri-
mary or adjuvant treatment modality for meningiomas and
many authors have reported excellent outcome for meningi-
omas treated with GKS.1 3–6 8 10–19 We identified peritumorous
imaging changes on MRI after GKS in 23.6% of lesions. Most
of these did not exhibit any symptoms, and all of the sympto-
matic patients (9.3%) completely recovered. The detailed
mechanism and pathophysiology of perilesional imaging
changes after radiosurgery are unclear. Most peritumorous
imaging changes are believed to be attributable to vasogenic
oedema. Whether this is attributable to vascular endothelial
growth factor (VEGF)/vascular permeability factor (VPF), an
angiogenic growth factor present in most meningiomas,20–24 or
radiation injury to the vasculature is unknown.
There have been many reports about the risk factors for
oedema development after radiosurgery. Kalapurakal et al
reported that parasagittal location, presence of pretreatment
oedema, sagittal sinus occlusion, and radiation doses above 6
Gy per fraction, were significant risk factors for oedema devel-
opment after radiation therapy.25 In a multicentre review,
Kondziolka et al identified 18 of 185 patients with sympto-
matic oedema that required treatment after GKS.3 They
suggested that the presence of a pre-GKS neurological deficit
was the most important factor for subsequent symptomatic
oedema and that the tumour margin dose was not related to
onset of oedema after GKS. Several groups have also reported
that non-skull base meningiomas have a higher risk of peritu-
morous oedema after GKS.8 17 26 Ganz et al suggested that
oedema developed preferentially in non-basal tumours, espe-
cially those around the midline and sagittal sinus and in cases
with a margin tumour dose more than 18 Gy.17 Besides the
factors described above, patient age, histological finding,
tumour growth, oestrogen and progesterone receptor positiv-
ity, and presence of secretory and excretory granules by elec-
tron microscopy were suggested as possible risk factors for
peritumorous oedema.18 25 26
In our study, post-GKS peritumorous imaging changes
developed mostly in cerebral hemispheric meningiomas of the
convexity, parasagittal region, or falx cerebri. In univariate
analysis, tumour location (skull base or cerebral hemisphere),
maximum tumour dose, and tumour margin dose were corre-
lated with the occurrence of imaging changes after GKS.
However, in multivariate analysis tumour location was the
only significant factor. Other factors reported as significant by
other investigators, such as pre-existing oedema, occlusion of
venous sinus, or patient age, did not influence the occurrence
of imaging changes after GKS.
The influence of tumour location on the rate of occurrence
of imaging changes—that is, peritumorous oedema, seems to
be related to the different growth patterns of skull base and
hemispheric meningiomas (fig 4). While skull base meningi-
omas spread laterally along the cistern, maintaining a wide
base on the dura at the base of the skull, cerebral hemispheric
meningiomas are embedded in the brain, and, therefore, have
a wider contact area with the brain parenchyma than skull
base meningiomas. Unlike skull base meningiomas, which are
surrounded by cisterns, hemispheric meningiomas lack any
intervening arachnoid or cerbral spinal fluid barrier between
the tumour and cortical surface. Therefore, the brain
parenchyma surrounding hemispheric meningiomas seems to
be more easily affected by the oedema fluid.
GKS has played an important part in the treatment of skull
base meningiomas, because the surgical approach carries a
high risk of complications and recurrence.1 4–6 9–15 26 Skull base
meningiomas were over-represented in our study of GKS
treated meningiomas (57.7%), compared with their preva-
lence in the whole meningioma population. There are many
cranial nerves and critical structures around the skull base,
especially the cavernous sinus, and careful dose planning is
required.6 12 14 15 27
Themost critical structure is the optic pathway,whichmany
authors believe tolerates a radiation dose of less than 8 to 10
Gy.4 6 14 27 28 Girkin et al reported that optic neuropathy
developed 7 to 30 months after GKS for perichiasmal tumours
as an abrupt change in the visual field to a homonymous
hemianopic defect.29 MRI showed swelling and contrast
enhancement of the affected portion of the visual apparatus.
They suggested that risk factors for the development of radia-
tion optic neuropathy after GKS included dose to the optic
apparatus of greater than 8 Gy, previous conventional
radiation therapy, pre-existing anterior visual pathway dys-
function secondary to previous surgery or tumour compres-
sion, treatment plans based on computed tomography rather
than MRI, large tumour volume, and treatment isocentres
within 5 mm of the anterior visual pathways. Kondziolka et al
insisted that only a 1mm gap between tumourmargin and the
chiasm might be necessary, if this proximity occurred only at
one point, as verified with current high resolution imaging
techniques.4 Another report suggested that even more than 10
Gy was safe for the optic apparatus.12 However, we believe that
the radiation dose to the optic pathway should not exceed 10
Gy. In our studies, the dose to the optic pathway was less than
9.6 Gy and there were no visual complications. Recent
advances in neuroradiological imaging and radiosurgical
technique have permitted effective and safe control for
tumours with a closer contact to the optic pathway.6
Beyond the optic pathway, attention also should be paid to
the radiation dose to the cranial nerves running along the wall
of the cavernous sinus,Meckel’s cave, hypothalamus, pituitary
gland and stalk, and brain stem.6 12 14 27 28 We previously
suggested the optimal radiation dose for critical juxtasellar
structures.27 While 48 patients with radiosurgically treated
juxtasellar tumours with a dose of less than 16 Gy to the cav-
ernous sinus had no cranial nerve deficits, two other patients
with a dose of more than 16 Gy experienced cranial nerve
dysfunction. In this study, both of the patients with transient
cranial nerve dysfunctions, received more than 16.0 Gy to the
cranial nerves.
While 12 Gy to 15 Gy has been recommended as the mini-
mal dose for the meningioma margin,6 8 12 15 17 low dose radio-
surgery has been tried by several groups to avoid complica-
tions associated with radiation therapy.8 10 19 While a lower
dose may be sufficient for effective tumour control with
decreased complication rate, the follow up durations of these
low dose radiosurgery studies are comparatively short. The
minimal dose for tumour margin remains controversial and
longer follow up studies are needed.
In our study, we identified four failed cases of meningioma
after GKS. One patient had undergone GKS for a residual
convexity meningioma after surgical resection. The tumour
had nearly disappeared three years after GKS, but recurred on
follow up MRI taken at seven years after GKS. The recurrence
was thought to arise from the peritumorous dural extension
not included within a proper isodose curve. We believe it is
essential to irradiate the peritumorous dural extension
optimally to achieve long term tumour control.
In conclusion, GKS for intracranial meningiomas is a safe
and effective form of primary or adjuvant treatment after
incomplete surgical resection. However, patients with cerebral
hemispheric meningiomas of convexity, parasagittal region, or
falx cerebri have a higher incidence of peritumorous imaging
changes after GKS than those with skull base meningiomas.
These imaging changes are probably explained by postradio-
surgical peritumorous oedema. Therefore, patient age and
general condition, tumour size and location, pattern of cortical
embedding, relation between the tumour and venous sinuses,
presenting symptoms and patient preference need to be con-
sidered when treating hemispheric meningiomas with GKS.
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